Vetter
Vetter’s new Center for Visual Inspection and Logistics passed its first GMP inspection by the FDA. The inspection was conducted on 11–14 March 2013 to ensure the facility is in compliance with good manufacturing practices. The facility was already granted manufacturing approval and cGMP certification for Europa from the RP Tuebingen, Germany, in 2012.
The 18,000 m2 facility, known as Ravensburg Vetter West (RVW), began operations in April 2012. The site provides high-bay warehousing for cold storage and room-temperature products as well as visual inspection. Featuring state-of-the-art technology, which helps adapt to the needs of the separate supply and manufacturing processes, RVW also harnesses extensive use of renewable energy sources, including photovoltaic and geothermal.
“We’re pleased with the outcome of Ravensburg Vetter West’s first FDA GMP inspection,” said Managing Director Thomas Otto. “We at Vetter work diligently to meet regulatory requirements. Maintaining high quality standards is a job we take seriously to be a reliable and efficient partner for our customers.”
Vetter Pharma International GmbH, +49 751 3700 3023, prnews@vetter-pharma.com, www.vetter-pharma.com.